Department of Health reminds medical personnel and people to be aware of the limitations in blood sugar testing devices


The health authority of Canada warned that using certain types of drugs may interfere the testing results of non-glucose-specific blood sugar reagents (blood sugar measurement based on glucose dehydrogenase pyrroloquinolinequinone (GDH-PQQ) technique) resulting in a higher test blood sugar level than the actual level. These drugs include intravenously injected immunoglobulin, extraneal peritoneal dialysis solution for treatment of renal failure, drugs containing maltose, xylose or galactose, or drugs whose metabolites are maltose, xylose or galactose. Users of the testing product are warned about the use of these drugs.

The Department of Health would like to remind medical personnel and general users of blood sugar testing devices to be aware of whether the devices are affected as described above. Please consult relevant medical personnel for any questions to avoid an error in blood sugar testing result. Prior to use of the devices, users shall read instruction leaflets carefully (directions) and use blood sugar testing reagents for their specifically designed devices only to avoid incorrect testing results.

To assure the safety of use of in vitro diagnostic medical equipment in Taiwan, the Department would like to remind people or medical personnel to report any inferior medical equipment to the National Adverse Drug Reactions Reporting Center.
 
Source from Department of Health, Executive Yuan, R.O.C. (Taiwan)  Last update：2009/02/17